OSR Health (OSRHW) Treasury Shares (2023)
OSR Health (OSRHW) posted Treasury Shares of $3.5 million for Q4 2023, down 49.74% sequentially from $6.9 million in Q1 2023.
OSR Health (OSRHW) Treasury Shares (2023) Analysis & Trends
OSR Health has reported Treasury Shares for 1 years, with the latest figure at $3.5 million in Q4 2023.
- Quarterly Treasury Shares changed N/A year-over-year to $3.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $3.5 million (changed N/A YoY) and the FY2023 annual result came in at $3.5 million, changed N/A from the prior year.
- Treasury Shares eased to $3.5 million in Q4 2023 per OSRHW's latest filing, from $6.9 million in the prior quarter.
- Over five years, Treasury Shares peaked at $6.9 million in Q1 2023 and troughed at $3.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 2.72 Mn |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | - |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 3.47 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Mar 31, 2023 | 6.90 Mn |
| Mar 31, 2023 | 6.90 Mn |